CoChat

Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study

Open access
Midani, Deena, Parkman, Henry P · 2016 · Journal of Neurogastroenterology and Motility
Cited by 64

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background/AimsSerotonin receptor (eg, 5-HT 3 ) antagonists are used to treat nausea and vomiting from a variety of causes.Granisetron transdermal system (GTS) is an appealing delivery system for patients with gastroparesis.To assess if GTS improves nausea and vomiting and other gastroparesis symptoms in patients with gastroparesis. MethodsPatients with gastroparesis and symptoms of nausea and vomiting refractory to conventional treatment were treated with GTS.Symptoms of gastroparesis were assessed using a modified Gastroparesis Cardinal Symptom Index (GCSI).Following 2 weeks of treatment, patients were asked to assess their symptoms and indicate their therapeutic response using the Clinical Patient Grading Assessment Scale (CPGAS) reporting if symptoms of nausea and vomiting improved on a scale: 0 = no change to +7 = completely better. ResultsFifty-one patients received GTS by prescription: average age was 40 ± 17 years, 44 female, 11 diabetics, 23 ± 20% retention at 4 hours on gastric emptying scintigraphy.Thirty-nine of the 51 (76%) patients stated improvement with GTS.There was significant improvement in nausea and vomiting as assessed with CPGAS at 2 weeks (2.28 ± 2.53; P < 0.05).Symptoms of nausea and vomiting significantly improved.Other symptoms including postprandial fullness, loss of appetite, upper abdominal pain, and early satiety improved.Side effects reported included redness at the site of the patch in 7 patients, pruritus in 5, and constipation in 5. ConclusionsGTS was moderately effective in reducing nausea and/or vomiting in 76% of gastroparesis patients.In addition to nausea and vomiting, symptoms of postprandial fullness, loss of appetite, upper abdominal pain, and early satiety also improved.(

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5056/jnm15203

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 64

Metadata

Authors
Midani, D., & Parkman, H. P.
Venue
Journal of Neurogastroenterology and Motility
Published
2016-10-30
Volume
22
Issue
4
Pages
650-655
ISSN
  • 2093-0879 (ISSN-L)
  • 2093-0887
OpenAlex
W2468534258
Cited by
64
References
2
FWCI
5.51
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study. https://app.cochat.ai/papers/10.5056/jnm15203
The paper
Midani, D., & Parkman, H. P. (2016). Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study. Journal of Neurogastroenterology and Motility. https://doi.org/10.5056/jnm15203

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.